Work

Abstract CT054: Results from the phase 1b/2 Morpheus liver study in patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC): Muzastotug (ADG126: masked anti-CTLA-4 Ab) combination arm

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct054

Authors: Daneng Li, Edward Gane, Chih-Hung Hsu, Adam Burgoyne, Peter Luo, Songmao Zheng, Yan Li, Xiaohong She, Stanley Frankel, Jiping Zha, Ann-Lii Cheng

Institutions: City of Hope, Auckland City Hospital, National Taiwan University, University of California San Diego, University of California San Diego Medical Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154713145

Cites:

Cited by:

Related to: